Hexyl nicotinate

• CAT Number: I028749
• CAS Number: 23597-82-2
• Molecular Formula: C12H17NO2
• Molecular Weight: 207.27
• Purity: 98%
• Synonyms: Hexyl nicotinate; AI3-15769; AI3 15769; AI315769
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Room Temperature
• IUPAC Name: 3-Pyridinecarboxylic acid, hexyl ester
• InChI: InChI=1S/C12H17NO2/c1-2-3-4-5-9-15-12(14)11-7-6-8-13-10-11/h6-8,10H,2-5,9H2,1H3
• InChIKey: RVYGVBZGSFLJKH-UHFFFAOYSA-N
• SMILES: O=C(C1=CC=CN=C1)OCCCCCC

Hexyl nicotinate（Cat No.:I028749） is employed in the treatment of non-immunologic contact urticaria, specifically on the scalp, face, and back. This compound acts by causing a mild irritation or vasodilation of the skin, which results in increased blood flow and improved circulation. By stimulating blood flow to the affected areas, hexyl nicotinate helps alleviate symptoms such as itching, redness, and swelling associated with contact urticaria. It is commonly used in topical formulations, such as creams or ointments, for targeted application on the affected skin regions to provide localized relief.

Reference

1: Zhai H, Zheng Y, Fautz R, Fuchs A, Maibach HI. Reactions of non-immunologic contact urticaria on scalp, face, and back. Skin Res Technol. 2012 Nov;18(4):436-41. doi: 10.1111/j.1600-0846.2011.00590.x. Epub 2011 Nov 9. PubMed PMID: 22093067.
2: Wa CV, Maibach HI. Mapping the human face: biophysical properties. Skin Res Technol. 2010 Feb;16(1):38-54. doi: 10.1111/j.1600-0846.2009.00400.x. PubMed PMID: 20384882.
3: Sivamani RK, Stoeber B, Liepmann D, Maibach HI. Microneedle penetration and injection past the stratum corneum in humans. J Dermatolog Treat. 2009;20(3):156-9. doi: 10.1080/09546630802512679. PubMed PMID: 19016065.
4: Uchimura T, Kato M, Shiokawa R, Nabuchi Y, Saito K, Kinoshita H. Estimation of serum protein binding of compounds metabolized in serum using matrix inhibition. Biopharm Drug Dispos. 2008 Jul;29(5):308-10. doi: 10.1002/bdd.610. PubMed PMID: 18496881.
5: Marrakchi S, Maibach HI. Functional map and age-related differences in the human face: nonimmunologic contact urticaria induced by hexyl nicotinate. Contact Dermatitis. 2006 Jul;55(1):15-9. PubMed PMID: 16842548.
6: Müller B, Kasper M, Surber C, Imanidis G. Permeation, metabolism and site of action concentration of nicotinic acid derivatives in human skin. Correlation with topical pharmacological effect. Eur J Pharm Sci. 2003 Oct;20(2):181-95. PubMed PMID: 14550884.
7: Duval C, Lindberg M, Boman A, Johnsson S, Edlund F, Lodén M. Differences among moisturizers in affecting skin susceptibility to hexyl nicotinate, measured as time to increase skin blood flow. Skin Res Technol. 2003 Feb;9(1):59-63. PubMed PMID: 12535286.
8: Zhai H, Ebel JP, Chatterjee R, Stone KJ, Gartstein V, Juhlin KD, Pelosi A, Maibach HI. Hydration vs. skin permeability to nicotinates in man. Skin Res Technol. 2002 Feb;8(1):13-8. PubMed PMID: 12005115.
9: Weng Larsen S, Engelbrecht Thomsen AE, Rinvar E, Friis GJ, Larsen C. Effect of drug lipophilicity on in vitro release rate from oil vehicles using nicotinic acid esters as model prodrug derivatives. Int J Pharm. 2001 Mar 23;216(1-2):83-93. PubMed PMID: 11274810.
10: Tanojo H, Boelsma E, Junginger HE, Ponec M, Boddé HE. In vivo human skin permeability enhancement by oleic acid: a laser Doppler velocimetry study. J Control Release. 1999 Mar 8;58(1):97-104. PubMed PMID: 10021493.
11: Bettinger J, Gloor M, Peter C, Kleesz P, Fluhr J, Gehring W. Opposing effects of glycerol on the protective function of the horny layer against irritants and on the penetration of hexyl nicotinate. Dermatology. 1998;197(1):18-24. PubMed PMID: 9693180.
12: Tanojo H, Boelsma E, Junginger HE, Ponec M, Boddé HE. In vivo human skin barrier modulation by topical application of fatty acids. Skin Pharmacol Appl Skin Physiol. 1998 Mar-Apr;11(2):87-97. PubMed PMID: 9603659.
13: Boelsma E, Tanojo H, Boddé HE, Ponec M. An in vivo-In vitro study of the use of a human skin equivalent for irritancy screening of fatty acids. Toxicol In Vitro. 1997 Aug;11(4):365-76. PubMed PMID: 20654323.
14: Mills CM, Hill SA, Marks R. Transdermal nicotine suppresses cutaneous inflammation. Arch Dermatol. 1997 Jul;133(7):823-5. PubMed PMID: 9236519.
15: Barclay LR, Crowe E, Edwards CD. Photo-initiated peroxidation of lipids in micelles by azaaromatics. Lipids. 1997 Mar;32(3):237-45. PubMed PMID: 9076660.
16: Graves CJ, Edwards C, Marks R. The occlusive effects of protective gloves on the barrier properties of the stratum corneum. Curr Probl Dermatol. 1995;23:87-94. PubMed PMID: 9035931.
17: Gabard B, Treffel P, Charton-Picard F, Eloy R. Irritant reactions on hairless micropig skin: a model for testing barrier creams? Curr Probl Dermatol. 1995;23:275-87. PubMed PMID: 9035922.
18: Reinberg AE, Soudant E, Koulbanis C, Bazin R, Nicolaï A, Mechkouri M, Touitou Y. Circadian dosing time dependency in the forearm skin penetration of methyl and hexyl nicotinate. Life Sci. 1995;57(16):1507-13. PubMed PMID: 7564895.
19: Lavrijsen AP, Oestmann E, Hermans J, Boddé HE, Vermeer BJ, Ponec M. Barrier function parameters in various keratinization disorders: transepidermal water loss and vascular response to hexyl nicotinate. Br J Dermatol. 1993 Nov;129(5):547-53. PubMed PMID: 8251350.
20: Oestmann E, Lavrijsen AP, Hermans J, Ponec M. Skin barrier function in healthy volunteers as assessed by transepidermal water loss and vascular response to hexyl nicotinate: intra- and inter-individual variability. Br J Dermatol. 1993 Feb;128(2):130-6. PubMed PMID: 8457445.